All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
In Vitro-Transcribed (IVT) CAR
As one of the most promising adoptive immunotherapy for cancer, CAR-T therapy has achieved good therapeutic efficacy in antitumor therapy. However, due to current CAR T cell engineering is usually mediated via viral vectors that induce permanent CAR expression, there are safety concerns of permanent mutagenesis. In order to circumvent risk, in vitro-transcribed (IVT)-mRNA-mediated transfection is an attractive tool for rapid, facile, and safe CAR production. Based on the most advanced technology and years of experience, Creative Biolabs is dedicated to delivery of the state-of-the-art CAR therapies. our R&D scientists provide a one-stop CAR IVT products and services including IVT plasmid, IVT mRNA, and IVT LNP.
CAR IVT Plasmid Products
Creative Biolabs provides a one-stop solution for the development of CAR IVT products. Our IVT plasmid manufacturing workflow contains codon optimization, gene synthesis, vector design, and vector cloning, with many customizable options. Our team of experts provides professional support and technological guidance in each plasmid DNA production program, to make sure optimal plasmid production. A series of rigorous QC assays are performed to ensure the plasmid DNA template is optimal for downstream mRNA manufacturing. Based on extensive design and project experience, we have a high success rate using the IVT system. Working with us can help accelerate your project significantly.
Fig.1 Schematic overview of the synthesis of IVT mRNA. (Steinle, et al., 2017)
Browse the following CAR IVT plasmids we provide.
Custom Services
Creative Biolabs provides a service for the custom CAR IVT plasmids. If you do not find the desired products, please contact us. Simply provide us with the desired sequence data and we will generate a high IVT plasmid.
Fig.2 Workflow of CAR IVT plasmid production. (Creative Biolabs)
Reference
Associated Antigen Target
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION